◆ 会议时间：2023年11月15日至19日
◆ 会议地点：加拿大 温哥华

◆ 会议简介：

2023年第28届美国神经肿瘤学会(SNO)年会将于2023年11月15日至19日在加拿大温哥华举行。
SNO年会是世界上最大的神经肿瘤学会议，预计有来自40多个国家的2600多名研究人员和临床科学家及其他相关专业人士与会。SNO年会议题将涵盖所有神经肿瘤学学科、专业和兴趣，将是分享知识和获得对未来神经肿瘤学研究和治疗见解的首要论坛。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。

神经肿瘤学会（SNO）成立于1996年，是一个致力于通过研究和教育促进神经肿瘤学发展的非营利性多学科组织，SNO现拥有超过2000名成员，会员来自多个学科宣领域，包括流行病学、肿瘤学、神经肿瘤科、神经外科、病理、儿科、心理学、放射学、放射肿瘤学和基础科学等。二十多年来，SNO不断地成长发展，已经成为北美地区重点关注儿童和成人中枢神经系统肿瘤的临床医生、基础科学家、护士和其他卫生保健专业人员的主要组织。

摘要征文投稿：

点此提交摘要>>>Submit Abstract>>>

Important Information

• General Abstract Deadline is Friday, June 9, 2023, 11:59pm EDT.
• Late Breaking Abstract Deadline: Monday, September 4, 2023, 5:00pm EDT.
  Abstracts submitted to this category that do not fit the description criteria, will be withdrawn. For information and special guidelines on Late-Breaking Abstracts, click here.
  *Please use the web browser Google Chrome when submitting an abstract. In order to successfully submit your abstract, you must click on the "SUBMIT" button.
• All accepted abstracts will be published in SNO’s official journal, Neuro-Oncology. Abstracts cannot be edited or changed after the June 9th deadline.
• Once the accepted abstracts are submitted to the journal for publication, requests for withdrawals cannot be processed. All request to withdraw abstracts MUST be received by Wednesday, August 16, 2023, at 11:59 PM ET.
• Embargo Details:
• The embargo for abstracts published in the 2023 abstract supplement to SNO official journal Neuro-Oncology will lift on Friday, November 10, 2023.
• All accepted abstracts will be published and made available at: https://academic.oup.com/neuro-oncology/supplements.
• Presentation Recording Onsite:
• SNO will record all "live" slide presentations (with accompanying audio and video) during the meeting.
• Select presentations will be featured on the SNO Education Site and will be made available for online viewing.
• Traditional Poster Presentations:
• An in-person poster session will take place at the Annual Meeting. More details will be sent to the accepted poster presenters.
• Electronic Poster Presentations:
• Files will be captured electronically (in PDF) prior to the meeting and available on the mobile meeting app, website and onsite.
• Presenters will be given full credit for their presentations. For the purpose of Neuro-Oncology, Neuro-Oncology Practice, and other scholarly journals, presentation in either of these forums is not considered "prior publication."
• Registration Requirements: If your abstract is accepted for presentation at the 2023 SNO Annual Meeting, the presenting author is required to register for the meeting by the presenter registration deadline. If the presenting author does not register for the SNO Annual Meeting by this deadline, their abstract could be withdrawn from the program and will not be published in the Neuro-Oncology abstract supplement. Additional registration details will be provided in the acceptance email.
• Abstract submitters and attendees should not anticipate an option for remote participation.

• Abstract Title:
• Should be sentence case (i.e., only the first letter of the title should be capitalized)
• Should be plain text (No html)
• Word Limit: 75 words/ 200 characters
• Abstract Body:
• Word Limit: 300 words
• Figures and tables are not allowed
• Should be in a single paragraph
• If subheaders are used, they should be within that single paragraph in all-caps, not bolded (e.g., METHODS:)
• If you use the greater than/equal to symbol, you MUST put a space before entering the number.
• Abstracts should be data-driven and must include this information in the body of the abstract.
• Please be sure to carefully check your abstract for content errors, spelling, names, etc. before submitting. SNO neither proofreads for nor corrects spelling, typographical, grammatical, or scientific errors.
• Authors:
• There can only be 1 presenting author per submission.
  • In the the case that a presenter is unable to present, we will allow a co-author to present in their place, but we will be unable to make any edits to the printed journal.
  • The presenter must contact the SNO team immeidatedly to let us know of said change. 
• There is a maximum of 50 authors per abstract submission.
• Enter the names of authors in the order in which you wish them to appear in the printed text.
• Presenting Authors will need to complete the Presenting Author Task.
• For information and special guidelines on Late-Breaking Abstracts, click here.
• General Guidelines: 
  • Please make sure your abstract contains only generic drugs names. Abstracts with trade names in the title or body could be precluded from presentation.
  • Please be sure to carefully check your submission for content errors. SNO neither proofreads for nor corrects spelling, typographical, grammatical, or scientific errors. Errors made on your submitted abstract are likely to appear in print.
  • Please be sure to verify the presenters email address. All communication regarding the abstract will be sent to the presenting author’s email address that was entered at the time of submission.
  • If a Conflict of Interest Disclosure is required, you will be contacted directly by a SNO team member.

Dear Colleagues,

We are pleased to invite you to join your colleagues in the eclectic and vibrant city of Vancouver, British Columbia, Canada, for the 28th Annual Meeting of the Society for Neuro-Oncology! 

The SNO Annual Meeting is the world’s largest neuro-oncology conference, regularly attracting over 2600 researchers and clinician scientists from over 40 countries. Spanning all neuro-oncology disciplines, professions, and interests, SNO 2023 will be the premier forum at which to share knowledge and gain insights on the future of neuro-oncology research and treatment.

The theme of SNO 2023 is Neuro-Oncology at the Intersections: Multidisciplinary Approaches to Improve Patient Outcomes, and we are thrilled to share that an outstanding group of plenary speakers have already been confirmed, including:
 
Sriram Venneti
University of Michigan

Mark Bilsky
Memorial Sloan-Kettering Cancer Center

Benjamin Deneen
Baylor College of Medicine

Mariella Filbin
Dana-Farber Cancer Institute

Evanthia Galanis
Mayo Clinic

Information on additional speakers and panelists will be posted on this website in the coming weeks.

As British Columbia’s largest city, Vancouver is a haven for outdoor enthusiasts and cosmopolitan adventurers alike. Vancouver is known for its enviable mix of laid-back West Coast living and striking skyline, with the snow-capped Coastal Mountains as a picturesque backdrop. Surrounded by the waters of the Fraser River and Burrard Inlet, Vancouver has a mild climate and rain forest vegetation that make it an utterly unique North American city. Located on the Pacific Rim, it is a bustling seaport and tourist destination known for its ethnically diverse population and cosmopolitan urban core.

Against this backdrop, we believe this year’s SNO Annual Meeting will provide an outstanding opportunity for networking and building lasting relationships with like-minded colleagues from around the world.

We look forward to seeing you in Vancouver!

Sincerely,

Shawn Hervey-Jumper
Michelle Monje
Humsa Venkatesh

注册费：

General Information
The 28th Annual Meeting and Education Day of the Society for Neuro-Oncology will take place in-person only at the Vancouver Convention Centre from November 15-19, 2023. Take advantage of the early bird rate through Friday, September 15, 2023. After that, prices will increase.

Registration for the main scientific meeting includes:

• Access to all scientific and poster sessions, and Thursday evening Welcome Reception
• Access to the 2023 SNO Annual Meeting app and all abstracts
• Access to the Exhibit Hall
• Access to recorded audio and slides of select Annual Meeting content following the conference
• Poster e-Gallery

Meeting Rates
All prices are shown in US dollars (USD

*Please note that Education Day registration includes access to both the applied science and basic science tracks.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。